Featured Stories in the News
There are currently no news releases.
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
11/19/14BioTelemetry, Inc. Announces That Eric Prystowsky M.D. Will Transition From the Board of Directors Into a Medical Advisory Role
MALVERN, Pa., Nov. 19, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that after 13 years of distinguished service, Eric Prystowsky M.D., will transition from his position as a Director and enter into a multi-year agreement to serve as a Medical Advisor for the Company. Dr. Prystowsky received an undergraduate degree fro... 
Printer Friendly Version
10/30/14BioTelemetry, Inc. Reports Third Quarter 2014 Financial Results
MALVERN, Pa., Oct. 30, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2014. Company Highlights Revenue increased 35% to $43.1 million, which includes 9% organic growth Experienced ninth consecutive quarter of year over year revenue growth Serviced over... 
Printer Friendly Version
10/22/14BioTelemetry, Inc. to Release Third Quarter 2014 Earnings Results on October 30, 2014
MALVERN, Pa., Oct. 22, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its third quarter 2014 earnings on Thursday, October 30, 2014 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, October 30, 2014. The broadcast will be available through the investor information section of the BioTelemetry website www.biotelinc.com. If you are unable to participate during the live webcast, an archive will be available... 
Printer Friendly Version
10/16/14BioTelemetry, Inc. Announces Reinstatement of Cigna Corporation's Coverage of Mobile Cardiac Monitoring Services
MALVERN, Pa., Oct. 16, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Cigna Corporation will reinstate coverage of the Company's Mobile Cardiac Outpatient TelemetryTM service (MCOTTM). The Coverage will be effective retroactive to June 15, 2014 and applies to all Cigna affiliated entities. The Company entered in... 
Printer Friendly Version
07/31/14BioTelemetry, Inc. Reports Second Quarter 2014 Financial Results
MALVERN, Pa., July 31, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2014. Company Highlights Revenue increased 33% to $42.7 million, the highest quarterly revenue in the Company's history Serviced over 135,000 patients in the quarter, doubling our prior year v... 
Printer Friendly Version
07/22/14BioTelemetry, Inc. to Release Second Quarter 2014 Earnings Results on July 31, 2014
MALVERN, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its second quarter 2014 earnings on Thursday, July 31, 2014 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, July 31, 2014. The broadcast will be available through the investor information section of the BioTelemetry website www.biotelinc.com. If you are unable to participate during the live webcast, an archive will be available on o... 
Printer Friendly Version
06/05/14BioTelemetry, Inc. Announces Major Advancements in Research Services
Acquires RadCore Lab, LLC MALVERN, Pa., June 5, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Cardiocore, its research services subsidiary, acquired the assets of RadCore Lab, LLC ("RadCore"), an imaging core lab serving the biopharmaceutical and medical device research market. This acquisition broadens the Company's ... 
Printer Friendly Version
05/06/14BioTelemetry, Inc. Reports First Quarter 2014 Financial Results
MALVERN, Pa., May 6, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2014. Company Highlights Revenue increased 15% to $37.2 million, the highest quarterly revenue since 2009 Serviced over 100,000 patients in the quarter, the highest quarterly patient volume ever... 
Printer Friendly Version
04/30/14BioTelemetry, Inc. to Release First Quarter 2014 Earnings Results on May 6, 2014
MALVERN, Pa., April 30, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its first quarter 2014 earnings on Tuesday, May 6, 2014 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, May 6, 2014. The broadcast will be available through the investor information section of the BioTelemetry website www.biotelinc.com. If you are unable to participate during the live webcast, an archive will be available on our web... 
Printer Friendly Version
03/20/14BioTelemetry, Inc. Announces the Acquisition of the Cardiac Patient Services Business of Biomedical Systems, Corp.
MALVERN, Penn., March 20, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that it has entered into a definitive agreement to acquire the cardiac patient services business of Biomedical Systems, Corp. ("BMS") for aggregate consideration of $8.65 million at closing. Post integration, the acquisition is expected to generate $8.0 to $9... 
Printer Friendly Version
02/26/14BioTelemetry, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results
MALVERN, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year-ended December 31, 2013. Company Highlights Finished the year with fourth quarter revenue of $33.1 million and $5.2 million of adjusted EBITDA 16% revenue growth for the full year 2013 as compa... 
Printer Friendly Version
02/13/14BioTelemetry, Inc. to Release Fourth Quarter 2013 Earnings Results on February 26, 2014
MALVERN, Pa., Feb. 13, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its fourth quarter 2013 earnings on Wednesday, February 26, 2014 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 26, 2014. The broadcast will be available through the investor information section of the BioTelemetry website www.biotelinc.com. If you are unable to participate during the live webcast, an archive will be avai... 
Printer Friendly Version
02/03/14BioTelemetry, Inc. Announces Significant Patent Litigation Victory and the Acquisition of Mednet Healthcare Technologies, Inc.
MALVERN, Pa., Feb. 3, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a significant victory in the patent infringement case against Mednet Healthcare Technologies, Inc. and its subsidiaries, Heart-Care Corporation of America, Universal Medical Inc., and Universal Medical Laboratory, Inc. ("Mednet"), as well as other named def... 
Printer Friendly Version
01/06/14BioTelemetry, Inc. and Wellbridge Health, Inc. Announce Strategic Alliance
Collaboration to Market Creative and Cost Effective Congestive Heart Failure Solution MALVERN, Pa., Jan. 6, 2014 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and Well Bridge Health, Inc. ("Wellbridge Health"), a care management solutions company aimed at reducing unnecessary hospital re-admissions and emergency room visits resulting from cong... 
Printer Friendly Version


Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2009, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com